Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Neuro-Oncology|June 20, 2012
p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cellsLing Cen, Brett L Carlson, Mark A Schroeder, et al.Mayo Clinic Proceedings|September 2, 2009
Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreasGordon W Dewald, Thomas C Smyrk, Erik C Thorland, et al.Women'S Health (London, England)|April 29, 2023
Papanicolaou test collection with the Papette brush or the spatula with cytobrush: A pragmatic studyDanielle J O'Laughlin, Brittany A Strelow, Nicole A Fellows, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemiaTait D Shanafelt, Thomas E Witzig, Stephanie R Fink, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2009
Functional and clinical significance of variants localized to 8q24 in colon cancerMine S Cicek, Susan L Slager, Sara J Achenbach, et al.Nature Genetics|August 28, 2012
A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutationRobert B Jenkins, Yuanyuan Xiao, Hugues Sicotte, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 25, 2022
Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K StudyLiewei Wang, Steven E Scherer, Suzette J Bielinski, et al.Pageof 2